← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue decreased 9.7% to $35.46B, while Net income decreased 45.8% to $597.9M.
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $35.46BOK
- Profitability — Net income $597.9MOK
- Cash generation — Free cash flow ($92.8M)Note
- Accounting — Formula-grey distress score · manipulation screen not computed · earnings quality safeNote
- Insiders — 0 buys; 0 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Business
CHS INC: We buy commodities from and provide products and services to individual agricultural producers, local cooperatives and other companies (including our members and other nonmember customers), both domestically and internationally.
Where the revenue comes from
Fiscal 2025, as CHS INC reports it. History and quarterly detail are in the app.
- Ag$27.7B
- Energy$7.6B
- Corporate and Other$79.1M
Leadership changes
From CHS INC's own filings, the day they're filed.
- Daniel Schurr · Directors · departureeff. 2026-03-30
- Tony Rossman · appointmenteff. 2025-12-05
- Russ Kehl · appointmenteff. 2025-12-05
Latest filings
- 8-K · Company announcement2026-08-26
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-07-08
- 10-Q · Quarterly report2026-07-08
- 8-K · Company announcement2026-07-08
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CHS INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.